The Rheumatologist
COVID-19 News
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Ankylosing Spondylitis Resource Center
    • Gout Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Systemic Lupus Erythematosus Resource Center
      • Rheumatoid Arthritis Resource Center
      • Gout Resource Center
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / Study Probes Utility of Neutrophil Biomarkers in Rheumatoid Arthritis

Study Probes Utility of Neutrophil Biomarkers in Rheumatoid Arthritis

December 14, 2020 • By Elizabeth Hofheinz, MPH, MEd

  • Tweet
  • Email
Print-Friendly Version / Save PDF
ALIOUI MA / shutterstock.com

ALIOUI MA / shutterstock.com

Neutrophils, often hailed as guardians against infections, are maligned when it comes to rheumatoid arthritis (RA) due to their role in both the initial stage and disease progression. A new multicenter work, “A Neutrophil Activation Biomarker Panel in Prognosis and Monitoring of Patients with Rheumatoid Arthritis,” seeks to expand the literature on this topic.1 The study, published in Arthritis & Rheumatology, examines whether neutrophil activation markers might be helpful in the diagnosis, prognosis and monitoring of RA patients.

You Might Also Like
  • Progress Slow in Development of Useful Biomarkers for Rheumatoid Arthritis Treatment
  • Neutrophil Extracellular Traps & Their Role in Autoimmunity
  • Rheumatology Research Foundation Grant Aids Investigations Into Rheumatoid Arthritis
Explore This Issue
December 2020
Also By This Author
  • Study Finds Young Adults with Lupus at High Risk for Depression

Co-author Christian Lood, PhD, assistant professor in the Division of Rheumatology, Department of Medicine, University of Washington, Seattle, notes, “Under normal conditions, neutrophils are terrific immune cells that will defend against any type of microbe. One of the many ways a neutrophil can combat intruders is through the formation of neutrophil extracellular traps (NETs), also called NETosis. NET formation is a process by which DNA and other antimicrobial agents are ejected from the neutrophil in a sticky net that traps and kills pathogens. The problem for those with RA is that if all of the NET fragments are not removed, then autoantibodies directed against NET-related proteins and DNA can form, resulting in the development of RA (or lupus).

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

“My co-authors and I wanted to explore whether NETs are present in the circulation of RA patients and the extent to which they contribute to inflammation and disease progression,” he says.

A Close Look at Cellular Death

“During NETosis, the amino acid arginine is converted into citrulline, an event that makes the immune system of RA patients run amok, identifying the citrullinated self-molecules as foreign. The formation of these antibodies toward citrullinated peptides, ACPA, is used clinically for RA diagnosis,” Dr. Lood explains.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

“In healthy individuals, NETs are promptly removed from the circulation. However, RA patients have a lower capacity to degrade the NETs, which is why they are essentially left hanging around; this induces inflammation and organ damage,” he notes.

“Prior studies have indicated that RA patients may have elevated levels of NETs in serum samples,” says Dr. Lood. However, he notes that because the neutrophils are fragile and undergo NET formation upon serum processing, assessing serum levels alone may not reflect the true physiological levels of neutrophil extracellular traps in RA patients.

Dr. Lood

‘By combining existing panels with this neutrophil marker, we will have a much better ability to identify patients at high risk of the most devastating forms of RA.’  —Christian Lood, PhD

To address this gap in the literature, Dr. Lood and his colleagues studied 101 patients with RA who were age- and gender-matched with 20 healthy participants. Disease activity was recorded using the CDAI (Clinical Disease Activity Index) for RA, taking into account tender and swollen joints, patient global assessment and provider global assessment.

“When we looked at plasma samples to determine the true levels of NETs in patient circulation, we found that RA patients had profoundly elevated levels of NETs as compared to healthy individuals,” Dr. Lood says. “Similarly, another marker of neutrophil activation, calprotectin, was useful in monitoring patients [because] it tracks very well with disease activity. In our study, both calprotectin and NETs were better than C-reactive protein in identifying patients with active RA.”

Commenting on the finding that NET levels are high even among RA patients in remission, Dr. Lood notes, “It was quite surprising to see patients with no signs of the disease have such a high degree of neutrophil activity. In fact, we found that levels of NETs, as well as calprotectin, predicted development of a common extra-articular disease modification—RA nodules—as well as erosive disease. Also concerning is that this low-grade inflam­mation may play a role in the development of cardiovascular disease.”

“The most exciting aspect of this work is that we can predict what will happen to patients,” Dr. Lood says. “If, at an RA patient’s initial visit, we find that he or she has this marker for NETosis, then we can predict long term if they will develop severe extra-
articular manifestations. If we can identify these patients early on, then we can be aggressive in trying to prevent joint disability.”

ad goes here:advert-3
ADVERTISEMENT
SCROLL TO CONTINUE

Pages: 1 2 | Single Page

Filed Under: Conditions, Research Reviews, Rheumatoid Arthritis Tagged With: Biomarkers, Diagnosis, neutrophilIssue: December 2020

You Might Also Like:
  • Progress Slow in Development of Useful Biomarkers for Rheumatoid Arthritis Treatment
  • Neutrophil Extracellular Traps & Their Role in Autoimmunity
  • Rheumatology Research Foundation Grant Aids Investigations Into Rheumatoid Arthritis
  • Biomarkers in Rheumatoid Arthritis Remain Elusive

Simple Tasks

Learn more about the ACR’s public awareness campaign and how you can get involved. Help increase visibility of rheumatic diseases and decrease the number of people left untreated.

Visit the Simple Tasks site »

Meeting Abstracts

Browse and search abstracts from the ACR Convergence and ACR/ARP Annual Meetings going back to 2012.

Visit the Abstracts site »

ACR Convergence

Don’t miss rheumatology’s premier scientific meeting for anyone involved in research or the delivery of rheumatologic care or services.

Visit the ACR Convergence site »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2021 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)

loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.
This site uses cookies: Find out more.